MK0476 Phase III Long-term Study -Perennial Allergic Rhinitis.
Phase of Trial: Phase III
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Montelukast (Primary)
- Indications Perennial allergic rhinitis
- Focus Adverse reactions
- Sponsors Merck & Co
- 14 Mar 2013 Actual end date changed from Aug 2005 to Feb 2005 as reported by ClinicalTrials.gov.
- 25 Oct 2008 New trial record.